TD Ameritrade Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-134
| Closed | -$2K | – | 434 |
|
|
2023
Q2 | $2K | Hold |
134
| – | – | ﹤0.01% | 477 |
|
|
2023
Q1 | $2K | Sell |
134
-283
| -68% | -$4.22K | ﹤0.01% | 508 |
|
|
2022
Q4 | $7K | Sell |
417
-373
| -47% | -$6.26K | ﹤0.01% | 419 |
|
|
2022
Q3 | $10K | Sell |
790
-190
| -19% | -$2.41K | ﹤0.01% | 389 |
|
|
2022
Q2 | $14K | Sell |
980
-626
| -39% | -$8.94K | ﹤0.01% | 404 |
|
|
2022
Q1 | $23K | Sell |
1,606
-429
| -21% | -$6.14K | ﹤0.01% | 408 |
|
|
2021
Q4 | $28K | Sell |
2,035
-694
| -25% | -$9.55K | ﹤0.01% | 389 |
|
|
2021
Q3 | $49K | Buy |
2,729
+302
| +12% | +$5.42K | ﹤0.01% | 330 |
|
|
2021
Q2 | $41K | Sell |
2,427
-788
| -25% | -$13.3K | ﹤0.01% | 361 |
|
|
2021
Q1 | $59K | Hold |
3,215
| – | – | ﹤0.01% | 318 |
|
|
2020
Q4 | $59K | Buy |
3,215
+486
| +18% | +$8.92K | ﹤0.01% | 318 |
|
|
2020
Q3 | $49K | Sell |
2,729
-117
| -4% | -$2.1K | ﹤0.01% | 330 |
|
|
2020
Q2 | $51K | Sell |
2,846
-784
| -22% | -$14K | ﹤0.01% | 308 |
|
|
2020
Q1 | $55K | Sell |
3,630
-514
| -12% | -$7.79K | ﹤0.01% | 285 |
|
|
2019
Q4 | $82K | Buy |
4,144
+279
| +7% | +$5.52K | ﹤0.01% | 262 |
|
|
2019
Q3 | $66K | Buy |
3,865
+145
| +4% | +$2.48K | ﹤0.01% | 253 |
|
|
2019
Q2 | $66K | Buy |
3,720
+983
| +36% | +$17.4K | ﹤0.01% | 231 |
|
|
2019
Q1 | $56K | Buy |
2,737
+43
| +2% | +$880 | ﹤0.01% | 237 |
|
|
2018
Q4 | $45K | Buy |
+2,694
| New | +$45K | ﹤0.01% | 235 |
|